Cognition Therapeutics, Inc. (CGTX)
NASDAQ: CGTX · Real-Time Price · USD
0.440
0.00 (-0.05%)
At close: Nov 21, 2024, 4:00 PM
0.450
+0.010 (2.32%)
After-hours: Nov 21, 2024, 5:51 PM EST
Cognition Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Nov '24 Nov 21, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Market Capitalization | 18 | 59 | 61 | 139 | - | - |
| Market Cap Growth | -56.91% | -2.39% | -56.29% | - | - | - |
| Enterprise Value | -4 | 27 | 15 | 216 | - | - |
| Last Close Price | 0.44 | 1.85 | 2.10 | 6.32 | - | - |
| PB Ratio | 1.24 | 2.43 | 1.51 | 2.72 | - | - |
| P/TBV Ratio | 1.30 | 2.43 | 1.51 | 2.72 | - | - |
| Debt / Equity Ratio | 0.04 | 0.05 | 0.04 | - | -1.00 | -1.26 |
| Quick Ratio | 2.00 | 3.07 | 5.80 | 7.25 | 1.95 | 1.90 |
| Current Ratio | 2.11 | 3.37 | 6.11 | 7.50 | 2.13 | 1.94 |
| Return on Equity (ROE) | -157.90% | -79.69% | -46.76% | -60.93% | - | - |
| Return on Assets (ROA) | -110.08% | -74.08% | -49.69% | -53.95% | -149.26% | - |
| Return on Capital (ROIC) | -163.32% | -94.02% | -58.54% | -69.67% | -1506.84% | - |
| Earnings Yield | -193.24% | -43.40% | -35.15% | -8.41% | - | - |
| FCF Yield | -144.24% | -27.20% | -30.72% | -2.63% | - | - |
| Buyback Yield / Dilution | -25.67% | -27.03% | -355.42% | -921.60% | -8.18% | - |
| Total Shareholder Return | -25.67% | -27.03% | -355.42% | -921.60% | -8.18% | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.